4D-310
4D-310-C002
Phase 2 mab active
Quick answer
4D-310 for Fabry Disease is a Phase 2 program (mab) at 4D Molecular Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- 4D Molecular Therapeutics
- Indication
- Fabry Disease
- Phase
- Phase 2
- Modality
- mab
- Status
- active